Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Andrew Peter Selwyn, M.D., M.B.Ch.B.

Title
Institution
Department
Address
Phone

Mentoring
completed student projects
Mechanisms and Treatments of Arterial Dysfunction in Atherosclerosis
Part Time/Continuation, 09/07/98 - 01/07/99

Research
research activities and funding
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
Most Recent  |  List All
  1. R01HL050016 (SELWYN, ANDREW PETER) Apr 1, 1995 - Feb 29, 2000
    NIH
    TREATMENT OF CORONARY ENDOTHELIAL DYSFUNCTION
    Role: Principal Investigator
  2. N01HV018124 (SELWYN, ANDREW PETER) Dec 10, 1990 - Mar 31, 1994
    NIH/NHLBI
    ASYMPTOMATIC CARDIAC ISCHEMIA PILOT STUDY
    Role: Principal Investigator
  3. R01HL038780 (STONE, PETER HOWARD) Aug 1, 1989 - Jul 31, 2001
    NIH
    VASCULAR BASIS FOR THE TREATMENT OF ISCHEMIA
    Role: Co-Principal Investigator
  4. R01HL035295 (SELWYN, ANDREW PETER) Sep 8, 1986 - Sep 7, 1989
    NIH
    CAUSES OF TRANSIENT ISCHEMIA IN ANGINAL PATIENTS WITH CD
    Role: Principal Investigator
  5. M01RR002635 (GOTTLIEB, GARY L) Dec 1, 1984 - Mar 31, 2010
    NIH
    General Clinical Research Center
    Role: Co-Principal Investigator

Bibliographic
selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Campbell P, Leopold JA, Selwyn AP, Sisto D. Equalization of right- and left-sided intracardiac pressures: is it constriction? Circ Heart Fail. 2011 May; 4(3):369-73; discussion 374-7. PMID: 21586737.
    Citations:    Fields:    Translation:Humans
  2. Larose E, Behrendt D, Kinlay S, Selwyn AP, Ganz P, Fang JC. Endothelin-1 is a key mediator of coronary vasoconstriction in patients with transplant coronary arteriosclerosis. Circ Heart Fail. 2009 Sep; 2(5):409-16. PMID: 19808370.
    Citations: 3     Fields:    Translation:Humans
  3. Rawlings R, Nohria A, Liu PY, Donnelly J, Creager MA, Ganz P, Selwyn A, Liao JK. Comparison of effects of rosuvastatin (10 mg) versus atorvastatin (40 mg) on rho kinase activity in caucasian men with a previous atherosclerotic event. Am J Cardiol. 2009 Feb 15; 103(4):437-41. PMID: 19195498.
    Citations: 25     Fields:    Translation:Humans
  4. Nohria A, Prsic A, Liu PY, Okamoto R, Creager MA, Selwyn A, Liao JK, Ganz P. Statins inhibit Rho kinase activity in patients with atherosclerosis. Atherosclerosis. 2009 Aug; 205(2):517-21. PMID: 19167712.
    Citations: 56     Fields:    Translation:HumansCells
  5. Selwyn AP. Weight reduction and cardiovascular and metabolic disease prevention: clinical trial update. Am J Cardiol. 2007 Dec 17; 100(12A):33P-37P. PMID: 18154745.
    Citations: 6     Fields:    Translation:Humans
  6. Selwyn AP. Antiatherosclerotic effects of statins: LDL versus non-LDL effects. Curr Atheroscler Rep. 2007 Oct; 9(4):281-5. PMID: 18173955.
    Citations: 1     Fields:    Translation:HumansAnimals
  7. Sacher F, Sobieszczyk P, Tedrow U, Eisenhauer AC, Field ME, Selwyn A, Raymond JM, Koplan B, Epstein LM, Stevenson WG. Transcoronary ethanol ventricular tachycardia ablation in the modern electrophysiology era. Heart Rhythm. 2008 Jan; 5(1):62-8. PMID: 18180021.
    Citations: 26     Fields:    Translation:Humans
  8. Larose E, Kinlay S, Selwyn AP, Yeghiazarians Y, Yucel EK, Kacher DF, Libby P, Ganz P. Improved characterization of atherosclerotic plaques by gadolinium contrast during intravascular magnetic resonance imaging of human arteries. Atherosclerosis. 2008 Feb; 196(2):919-25. PMID: 17391676.
    Citations: 12     Fields:    Translation:Humans
  9. Behrendt D, Beltrame J, Hikiti H, Wainstein M, Kinlay S, Selwyn AP, Ganz P, Fang JC. Impact of coronary endothelial function on the progression of cardiac transplant-associated arteriosclerosis: effect of anti-oxidant vitamins C and E. J Heart Lung Transplant. 2006 Apr; 25(4):426-33. PMID: 16563973.
    Citations: 4     Fields:    Translation:Humans
  10. Larose E, Yeghiazarians Y, Libby P, Yucel EK, Aikawa M, Kacher DF, Aikawa E, Kinlay S, Schoen FJ, Selwyn AP, Ganz P. Characterization of human atherosclerotic plaques by intravascular magnetic resonance imaging. Circulation. 2005 Oct 11; 112(15):2324-31. PMID: 16203910.
    Citations: 37     Fields:    Translation:Humans
  11. Stone PH, Lloyd-Jones DM, Kinlay S, Frei B, Carlson W, Rubenstein J, Andrews TC, Johnstone M, Sopko G, Cole H, Orav J, Selwyn AP, Creager MA. Effect of intensive lipid lowering, with or without antioxidant vitamins, compared with moderate lipid lowering on myocardial ischemia in patients with stable coronary artery disease: the Vascular Basis for the Treatment of Myocardial Ischemia Study. Circulation. 2005 Apr 12; 111(14):1747-55. PMID: 15809368.
    Citations: 16     Fields:    Translation:HumansCTClinical Trials
  12. Larose E, Kinlay S, Selwyn A, Yeghiazarians Y, Yucel EK, Kacher D, Aikawa M, Rabkin-Aikawa E, Ganz P. ; Montreal, QC Canada . Intravascular magnetic resonance imaging with Godolinium- DTPA contrast for characterization of atherosclerotic plaques in patients. (Abstract). Can Cardiovascular Congress. 2005.
  13. Soejima K, Stevenson WG, Sapp JL, Selwyn AP, Couper G, Epstein LM. Endocardial and epicardial radiofrequency ablation of ventricular tachycardia associated with dilated cardiomyopathy: the importance of low-voltage scars. J Am Coll Cardiol. 2004 May 19; 43(10):1834-42. PMID: 15145109.
    Citations: 101     Fields:    Translation:Humans
  14. Fernandes JL, Mamoni RL, Orford JL, Garcia C, Selwyn AP, Coelho OR, Blotta MH. Increased Th1 activity in patients with coronary artery disease. Cytokine. 2004 May 07; 26(3):131-7. PMID: 15135807.
    Citations: 27     Fields:    Translation:HumansCells
  15. Stone PH, Lloyd-Jones DM, Johnstone M, Carlson W, Rubenstein J, Creager M, Frei B, Sopko G, Clark ME, Maccallum G, Kinlay S, Orav J, Selwyn AP. Vascular basis for the treatment of myocardial ischemia study: trial design and baseline characteristics. Am Heart J. 2004 May; 147(5):875-82. PMID: 15131545.
    Citations:    Fields:    Translation:HumansCTClinical Trials
  16. Kinlay S, Behrendt D, Fang JC, Delagrange D, Morrow J, Witztum JL, Rifai N, Selwyn AP, Creager MA, Ganz P. Long-term effect of combined vitamins E and C on coronary and peripheral endothelial function. J Am Coll Cardiol. 2004 Feb 18; 43(4):629-34. PMID: 14975474.
    Citations: 22     Fields:    Translation:HumansCTClinical Trials
  17. Larose E, Yeghiazarians Y, Selwyn AP, Kinlay S, Yucel EK, Kacher DM, Aikawa M, Rabkin E, Schoen FJ, Libby P, Ganz P. ; . Characterization of atherosclerotic plaques using high-resolution intravascular magnetic resonance imaging. (Abstract). Can J Cardiol. 2004; 20(supplement D)::139D.
  18. Larose E, Behrendt D, Kinlay S, Selwyn A, Ganz P, Fang J. . Endogenous endothelin-1: A potent coronary vasoconstrictor in cardiac transplant recipients with atherosclerosis. (Abstract). Circulation. 2004; 110(17)::III-584.
  19. Larose E, Yeghiazarians Y, Yucel EK, Kacher D, Aikawa M, Rabkin-Aikawa E, Libby P, Kinlay S, Selwyn A, Ganz P. . Intravascular magnetic resonance imaging to characterize the composition of human atherosclerotic in vivo. (Abstract). Circulation. 2004; 110(17)::III-733.
  20. Gonzalez MA, Selwyn AP. Endothelial function, inflammation, and prognosis in cardiovascular disease. Am J Med. 2003 Dec 08; 115 Suppl 8A:99S-106S. PMID: 14678874.
    Citations: 61     Fields:    Translation:Humans
  21. Selwyn AP. Prothrombotic and antithrombotic pathways in acute coronary syndromes. Am J Cardiol. 2003 Jun 19; 91(12A):3H-11H. PMID: 12818729.
    Citations: 12     Fields:    Translation:Humans
  22. Kinlay S, Selwyn AP. Effects of statins on inflammation in patients with acute and chronic coronary syndromes. Am J Cardiol. 2003 Feb 20; 91(4A):9B-13B. PMID: 12615293.
    Citations: 7     Fields:    Translation:Humans
  23. Fang JC, Kinlay S, Behrendt D, Hikita H, Witztum JL, Selwyn AP, Ganz P. Circulating autoantibodies to oxidized LDL correlate with impaired coronary endothelial function after cardiac transplantation. Arterioscler Thromb Vasc Biol. 2002 Dec 01; 22(12):2044-8. PMID: 12482832.
    Citations: 10     Fields:    Translation:HumansCells
  24. Kinlay S, Grewal J, Manuelin D, Fang JC, Selwyn AP, Bittl JA, Ganz P. Coronary flow velocity and disturbed flow predict adverse clinical outcome after coronary angioplasty. Arterioscler Thromb Vasc Biol. 2002 Aug 01; 22(8):1334-40. PMID: 12171797.
    Citations: 2     Fields:    Translation:Humans
  25. Adams MR, Orford JL, Blake GJ, Wainstein MV, Byrne JG, Selwyn AP. Rescue percutaneous coronary intervention following coronary artery bypass graft--a descriptive analysis of the changing interface between interventional cardiologist and cardiac surgeon. Clin Cardiol. 2002 Jun; 25(6):280-6. PMID: 12058791.
    Citations: 4     Fields:   &n